What Aegerion Pharmaceuticals, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Vanlent Anne | Director | Nov 29 | Disposition to Issuer · D | −4,000 | — | — | 0 |
| Barer Sol J | Director | Nov 29 | Disposition to Issuer · D | −29,890 | — | — | 0 |
| Thomas Paul | Director | Nov 29 | Disposition to Issuer · D | −36,978 | — | — | 0 |
| Broadfin Healthcare Master Fund Ltd | 10% owner | Nov 29 | Disposition to Issuer · D | −4,361,291 | — | — | 0 |
| Gotto Antonio M Jr Md D Phil | Director | Nov 29 | Disposition to Issuer · D | −13,916 | — | — | 0 |
| Scheer David | Director | Nov 29 | Disposition to Issuer · D | −521,350 | — | — | 0 |
| Scheer David | Director | Nov 29 | Disposition to Issuer · D | −10,000 | — | — | 0 |
| Smith Sandford D | Director | Nov 29 | Disposition to Issuer · D | −2,890 | — | — | 0 |
| Harshbarger Benjamin | General Counsel and Secretary | Nov 29 | Disposition to Issuer · D | −1,704 | — | — | 0 |
| Harshbarger Benjamin | General Counsel | Sep 17 | Withheld — tax / exercise cost · F | −532 | $1.78 | −$947 | 1,704 |
| Harshbarger Benjamin | General Counsel | Sep 17 | Exercise / conversion · M | +1,642 | — | — | 2,236 |
| Broadfin Healthcare Master Fund Ltd | 10% owner | Sep 13 | Open-market buy · P | +75,000 | $1.75 | +$131K | 4,361,291 |
| Broadfin Healthcare Master Fund Ltd | 10% owner | Sep 12 | Open-market buy · P | +76,000 | $1.70 | +$129K | 4,286,291 |
| Broadfin Healthcare Master Fund Ltd | 10% owner | Sep 12 | Open-market buy · P | +100,000 | $1.70 | +$170K | 4,210,291 |
| Broadfin Healthcare Master Fund Ltd | 10% owner | Sep 09 | Open-market buy · P | +100,000 | $1.60 | +$160K | 4,110,291 |
| Smith Sandford D | Director | Jul 27 | Withheld — tax / exercise cost · F | −777 | $1.55 | −$1.2K | 2,890 |
| Smith Sandford D | Director | Jul 27 | Exercise / conversion · M | +2,222 | — | — | 3,667 |
| Harshbarger Benjamin | General Counsel | Apr 01 | Withheld — tax / exercise cost · F | −273 | $3.55 | −$969 | 594 |
| Harshbarger Benjamin | General Counsel | Apr 01 | Exercise / conversion · M | +867 | — | — | 867 |
| Broadfin Healthcare Master Fund Ltd | 10% owner | Mar 18 | In/At-money Exercise · X | +497,600 | $7.50 | +$3.73M | 4,010,291 |
Loading...
